The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB)
- PMID: 15698741
- DOI: 10.1016/j.ejso.2004.10.009
The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB)
Comment on
-
Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.Eur J Surg Oncol. 2004 Aug;30(6):686-91. doi: 10.1016/j.ejso.2004.04.004. Eur J Surg Oncol. 2004. PMID: 15256245 Review.